Orchid Chemicals bags USFDA approval for oral formulations plant

The drug firm has received the USFDA approval for its Chennai plant.

 

New Delhi, June 17, 2013: The Indian drug firm, Orchid Chemicals and Pharmaceuticals, today said that US health regulator has inspected and accepted its oral formulations facility near Chennai.

 

The oral formulations facility of the company based at Irungattukottai near Chennai was "successfully inspected and accepted by the United States Food and Drug Administration (USFDA) without any observations," Orchid Chemicals & Pharmaceuticals said in a filing to BSE.

 

It may be noted here that the company manufactures  various types of dosage forms such as oral tablets and capsules in diverse dosage strengths at this facility.

 

Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...